Annabelle M Warren, Mathis Grossmann, Rudolf Hoermann, Rose Lin, Jeffrey D Zajac, Nicholas Russell
{"title":"对Sumi和Tominaga致编辑的信的回应:“托伐普坦与限制液体治疗中度深度低钠血症:一项开放标签随机临床试验”。","authors":"Annabelle M Warren, Mathis Grossmann, Rudolf Hoermann, Rose Lin, Jeffrey D Zajac, Nicholas Russell","doi":"10.1210/clinem/dgaf538","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":520805,"journal":{"name":"The Journal of clinical endocrinology and metabolism","volume":" ","pages":""},"PeriodicalIF":5.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Response to Letter to the Editor from Sumi and Tominaga: \\\"Tolvaptan versus fluid restriction in moderate-profound hyponatremia: An open-label randomized clinical trial\\\".\",\"authors\":\"Annabelle M Warren, Mathis Grossmann, Rudolf Hoermann, Rose Lin, Jeffrey D Zajac, Nicholas Russell\",\"doi\":\"10.1210/clinem/dgaf538\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":520805,\"journal\":{\"name\":\"The Journal of clinical endocrinology and metabolism\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of clinical endocrinology and metabolism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1210/clinem/dgaf538\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of clinical endocrinology and metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/clinem/dgaf538","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Response to Letter to the Editor from Sumi and Tominaga: "Tolvaptan versus fluid restriction in moderate-profound hyponatremia: An open-label randomized clinical trial".